Opioids Commonly Prescribed for Gout Attacks
Tanezumab’s Phase 3 Results for OA
IV Meloxicam Stalls at FDA; Plus Health Canada Approves Risankizumab for Plaque Psoriasis
Ibuprofen an Option for Early Pain Control after Hip Replacement
Arthralgias in Children: What to Do When Kids Present with Joint Pain
Emerging Treatments for OA: New Therapies Target Joint Pain, Not Just Structural Damage
Cerebral Blood Flow Variability May Provide Insights into Fibromyalgia
FDA Approves Opioid Treatment
5-Year Data on Secukinumab in AS; Oliceridine Not Recommended for FDA Approval
- 1
- 2
- 3
- …
- 24
- Next Page »